Modern Meadow Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
79
- Latest Deal Type
-
2ndary - Private
- Investors
-
42
Modern Meadow General Information
Description
Operator of a purpose-driven protein application powerhouse intended to produce fermentation-based bio-collagen. The company utilizes the power of proteins to engineer lightweight materials with superior color, performance, and durability while promoting lab-to-brand traceability and significantly reducing GHG emissions, enabling customers to maintain the skin's biological function so that it retains its quality and appearance, without the use of petrochemical inputs, animal-derived materials or chemical processes.
Contact Information
Website
www.modernmeadow.comCorporate Office
- 111 Ideation Way
- Suite 100
- Nutley, NJ 07110
- United States
Corporate Office
- 111 Ideation Way
- Suite 100
- Nutley, NJ 07110
- United States
Modern Meadow Timeline
Modern Meadow Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 8. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 7. Later Stage VC (Series D) | 25-Jul-2023 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 28-Apr-2021 | Completed | Generating Revenue | |||
| 5. Debt - PPP | 16-Apr-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 28-Jun-2016 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 05-Sep-2014 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jun-2012 | $250K | $50K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 17-May-2012 | $50K | $50K | Completed | Generating Revenue |
Modern Meadow Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 7,129,732 | $0.000100 | 5% | $5.61 | $5.61 | 1x | $5.61 | 10.24% |
| Series A | 6,592,832 | $0.000100 | 5% | $2.96 | $2.96 | 1x | $2.96 | 9.47% |
Modern Meadow Comparisons
Industry
Financing
Details
Modern Meadow Competitors (5)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Spiber | Private Equity-Backed | Tsuruoka, Japan | ||||
| Toray Advanced Materials Korea | Corporation | Seoul, South Korea | ||||
| Bolt Threads | Formerly VC-backed | Emeryville, CA | ||||
| 3M | Corporation | Saint Paul, MN | ||||
| Mitsui & Company | Corporation | Tokyo, Japan |
Modern Meadow Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Modern Meadow Patents
Modern Meadow Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023257357-A1 | Polyurethane fibers and methods of making the same | Pending | 18-Apr-2022 | ||
| CA-3231783-A1 | Protein polyurethane alloys comprising a succinylated protein and methods of making the same | Pending | 29-Oct-2021 | ||
| AU-2022377626-A1 | Protein polyurethane alloys comprising a succinylated protein and methods of making the same | Pending | 29-Oct-2021 | ||
| EP-4423193-A1 | Protein polyurethane alloys comprising a succinylated protein and methods of making the same | Pending | 29-Oct-2021 | ||
| CA-3174981-A1 | Collagen compositions and methods of use thereof | Pending | 30-Apr-2021 | A61L26/0033 |
Modern Meadow Executive Team (17)
| Name | Title | Board Seat |
|---|---|---|
| David Williamson Ph.D | Chief Science & Technology Officer, President and Chief Operating Officer | |
| Pinky Lakhia | Chief Human Resources Officer | |
| Quintin Cassady JD | General Counsel | |
| Andras Forgacs | Co-Founder & Board Member |
Modern Meadow Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Andras Forgacs | Self | Co-Founder & Board Member | |
| Anna Bakst | Self | Executive Chairman | |
| Bart Swanson | Horizons Ventures | Board Member | |
| Bill Ghitis | Self | Executive Chair of Board of Directors | |
| Dennis Fenton Ph.D | Self | Board Member |
Modern Meadow Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Modern Meadow Investors (42)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Chanel | Corporation | Minority | ||
| David Eisenberg | Angel (individual) | Minority | ||
| Kohala Ventures | Venture Capital | Minority | ||
| Mark Clark | Angel (individual) | Minority | ||
| Mark Davis | Angel (individual) | Minority |
Modern Meadow Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BioFabbrica | 12-Oct-2021 | Synthetic Textiles |
Modern Meadow FAQs
-
When was Modern Meadow founded?
Modern Meadow was founded in 2011.
-
Who is the founder of Modern Meadow?
Francoise Marga Ph.D, Karoly Jakab, Andras Forgacs, and Gabor Forgacs Ph.D are the founders of Modern Meadow.
-
Where is Modern Meadow headquartered?
Modern Meadow is headquartered in Nutley, NJ.
-
What is the size of Modern Meadow?
Modern Meadow has 79 total employees.
-
What industry is Modern Meadow in?
Modern Meadow’s primary industry is Biotechnology.
-
Is Modern Meadow a private or public company?
Modern Meadow is a Private company.
-
What is Modern Meadow’s current revenue?
The current revenue for Modern Meadow is .
-
How much funding has Modern Meadow raised over time?
Modern Meadow has raised $236M.
-
Who are Modern Meadow’s investors?
Chanel, David Eisenberg, Kohala Ventures, Mark Clark, and Mark Davis are 5 of 42 investors who have invested in Modern Meadow.
-
Who are Modern Meadow’s competitors?
Spiber, Toray Advanced Materials Korea, Bolt Threads, 3M, and Mitsui & Company are competitors of Modern Meadow.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
